What is the current market size?

The Non-Invasive Drug Delivery Device market size was valued at USD 1.2 billion in 2023, driven by demand for patient-friendly administration methods.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by advancements in transdermal and pulmonary delivery systems.

What are the key growth drivers?

Key drivers include rising chronic disease prevalence, preference for pain-free administration, and innovations in microneedle and patch technologies.

What challenges does the market face?

Challenges include high R&D costs, regulatory hurdles, and limited drug compatibility with non-invasive routes like nasal or transdermal systems.

Which regions lead the market?

North America dominates with a 40% share due to advanced healthcare infrastructure, followed by Europe, driven by technological adoption.

Who are the top companies?

Leading players include Medtronic, 3M, Becton Dickinson, and Owen Mumford, focusing on product innovation and strategic partnerships.

What future opportunities exist?

Opportunities lie in personalized drug delivery, IoT-enabled devices, and expansion into emerging markets with improving healthcare access.

How does technology impact growth?

Technologies like biodegradable microneedles, smart patches, and AI-driven dose optimization are accelerating adoption and improving efficacy.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA emphasize safety and bioavailability standards, requiring rigorous clinical trials for approval.

How does the market compare to invasive alternatives?

Non-invasive devices capture 30% of the drug delivery market, offering advantages in patient compliance over injections or infusions.

Non-Invasive Drug Delivery Device - Strategic Insights: Analysis 2025 and Forecasts 2033

Non-Invasive Drug Delivery Device by Application (Diabetes Management, Vaccine Management, Pain Management, Respiratory Management, Others), by Types (Liquid-Based Needle-Free Injector, Powder-Based Needle-Free Injector), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Non-Invasive Drug Delivery Device Market Size | CAGR 8.2 Forecast 2033

Non-Invasive Drug Delivery Device - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-Invasive Drug Delivery Device Market Overview

The Non-Invasive Drug Delivery Device market encompasses advanced medical technologies that administer therapeutic agents without penetrating the skin or mucosal barriers, offering improved patient compliance and reduced infection risks. As the Non-Invasive Drug Delivery Device market size is projected to reach $14.5 billion by 2026, driven by innovations in transdermal patches, nebulizers, and microneedle systems, the growth outlook remains robust. This market forecast highlights a 7.5% CAGR from 2026 to 2033, underpinned by rising demand for home healthcare solutions and chronic disease management. Key macro drivers include regulatory support for patient-centric therapies, advancements in smart drug delivery systems, and the global shift toward non-invasive alternatives to traditional parenteral injections.

Loading chart…

North America currently dominates the Non-Invasive Drug Delivery Device market, accounting for 38% of global revenue in 2025, while Asia-Pacific is emerging as the fastest-growing region due to rising healthcare investments and expanding diabetes and respiratory disease populations. Technological shifts, such as AI-integrated patches and biodegradable microneedles, are reshaping the competitive landscape. Regulatory harmonization and partnerships between pharmaceutical giants and device innovators are critical to scaling adoption. Strategic insights indicate that companies prioritizing digital therapeutics integration and patient-centric design will lead industry expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	23.48 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Novartis AG; Inovio Pharmaceuticals, Inc.; Medtronic Plc.; Tandem Diabetes Care, Inc.; Teva Pharmaceutical Industries Ltd.; Crossject Medical Technology; Adherium Ltd.; Sensirion AG; Diabeloop; PharmaJet; PenJet; Portal Instruments; Capsule Technologies; Propeller Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for patient-centric treatment options is propelling the Non-Invasive Drug Delivery Device market. Chronic disease prevalence and aging populations are driving adoption of needle-free solutions, such as transdermal patches and nebulizers, which enhance patient compliance and reduce healthcare provider workload.

Government funding and R&D investments are accelerating innovation in drug delivery technologies. Initiatives by agencies like the FDA and EMA to fast-track approvals for Non-Invasive Drug Delivery Device market size-expanding therapies (e.g., biologics via nasal sprays) are fostering market growth, supported by favorable reimbursement policies in high-income economies.

Restraints2 items

High development costs and regulatory complexity hinder market expansion. Non-invasive devices often require multi-phase clinical trials to prove bioavailability equivalent to injectables, delaying commercialization and increasing capital expenditures for manufacturers.

Technological limitations in drug absorption remain a barrier. Challenges in achieving consistent dosing for large-molecule drugs (e.g., peptides, proteins) via non-invasive routes limit the therapeutic scope, particularly for oncology and rare disease indications.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer untapped potential. Rising disposable incomes and healthcare infrastructure investments are driving demand for Non-Invasive Drug Delivery Device market solutions, particularly in diabetes management and respiratory therapies.

Smart delivery systems integration is unlocking new revenue streams. IoT-enabled patches and AI-driven dose optimization are attracting partnerships between device makers and pharma firms, positioning the market for growth forecast exceeding 12% CAGR by 2030.

Challenges2 items

Regulatory fragmentation across regions complicates global market access. Divergent standards for safety, efficacy, and manufacturing between the EU, U.S., and Asia-Pacific create compliance costs and delay cross-border commercialization.

Competition from established injectable therapies pressures pricing and margins. Cost-conscious payers often favor low-cost, well-established injectables, forcing non-invasive device innovators to demonstrate superior clinical outcomes to justify premium pricing.

Market Segmentation

Loading chart…

Non-Invasive Drug Delivery Device segmentation by application reveals distinct end-use categories driving market dynamics. The chronic disease management segment dominates, accounting for ~55% of demand, due to rising prevalence of diabetes and respiratory disorders. Acute care applications, such as anesthesia and post-surgical pain relief, contribute ~30%, leveraging rapid-acting delivery systems. The preventive healthcare segment (~15%) is emerging, fueled by consumer interest in at-home diagnostics and prophylactic treatments. These applications collectively shape the market taxonomy by highlighting unmet needs in patient compliance, dosage accuracy, and device portability.

Types of Non-Invasive Drug Delivery Devices are categorized into inhalation, transdermal, and topical systems. Inhalation devices (e.g., metered-dose inhalers, nebulizers) dominate respiratory treatment, with ~40% market share, driven by asthma and COPD management. Transdermal patches (~35% share) benefit from steady growth in pain management and hormone therapy, emphasizing patient convenience. Topical systems (25% share), including nasal sprays and transmucosal devices, are expanding due to advancements in bioavailability enhancement. This market taxonomy underscores technological innovation and therapeutic versatility as key growth drivers.

Non-Invasive Drug Delivery Device Segmentation Breakdown9 items

Application

Diabetes Management

Vaccine Management

Pain Management

Respiratory Management

Others

Types

Liquid-Based Needle-Free Injector

Powder-Based Needle-Free Injector

Regional Insights

Loading chart…

North America dominates the Non-Invasive Drug Delivery Device market growth with a 35% share, driven by advanced healthcare infrastructure, high adoption of smart devices, and robust R&D investments. _Europe_ follows closely at 25%, supported by stringent regulatory frameworks fostering innovation and strong government funding for chronic disease management. The Asia Pacific region, registering the fastest growth at 9% CAGR, is propelled by rising geriatric populations, increasing prevalence of diabetes, and expanding pharmaceutical partnerships. Latin America (15% share) benefits from improving healthcare access and growing private-sector investments, while the Middle East & Africa (5% share) sees momentum from urbanization and public-private infrastructure projects.

Key drivers include policy mandates in North America and Europe to reduce invasive procedures, accelerating Non-Invasive Drug Delivery Device market adoption. Asia Pacific’s growth is fueled by demographic shifts and cost-effective device manufacturing hubs. Latin America leverages ecosystem maturity through cross-border collaborations, while the Middle East & Africa prioritize infrastructure upgrades to meet rising demand. Collectively, these regions shape a regional forecast of $XX billion by 2030, with Asia Pacific emerging as a strategic growth engine.

Competitive Landscape

The Non-Invasive Drug Delivery Device market remains moderately consolidated, with a mix of global innovators and regional specialists. The Non-Invasive Drug Delivery Device competitive landscape is shaped by advancements in pulmonary, transdermal, and nasal delivery technologies, alongside regulatory approvals (e.g., FDA 510(k) or CE marking) and strategic geographic expansion. Pricing competition is intense in mature markets, while product differentiation hinges on proprietary mechanisms (e.g., microchip-based delivery) and partnerships with biopharma firms. Distribution networks and compliance with ISO 13485 standards further stratify the market.

Competitors leverage acquisitions, R&D alliances, and local manufacturing to mitigate supply chain risks and address cost pressures. Differentiation factors include miniaturized actuator designs (e.g., PharmaJet’s high-velocity jet injectors), patient-centric service models (e.g., Propeller Health’s digital adherence platforms), and customizable dose titration for chronic therapies. A key challenge is escalating compliance costs due to evolving regulatory frameworks, particularly in regions with fragmented reimbursement policies.

Novartis AG: R&D partnerships for novel delivery systems

Medtronic Plc.: Product innovation in wearable injectors

Teva Pharmaceutical Industries Ltd.: Cost-competitive generic device portfolio

Tandem Diabetes Care, Inc.: Vertical integration for pump-DMS ecosystem

Inovio Pharmaceuticals, Inc.: Clinical trials expansion for DNA vaccines

Adherium Ltd.: Digital health integration with smart inhalers

Key Non-Invasive Drug Delivery Device Companies14 items

Novartis AG

Inovio Pharmaceuticals, Inc.

Medtronic Plc.

Tandem Diabetes Care, Inc.

Teva Pharmaceutical Industries Ltd.

Crossject Medical Technology

Adherium Ltd.

Sensirion AG

Diabeloop

PharmaJet

PenJet

Portal Instruments

Capsule Technologies

Propeller Health

Market Ecosystem

The Non-Invasive Drug Delivery Device ecosystem spans upstream raw material sourcing, midstream device development, and downstream clinical deployment. Value is generated through innovation in delivery mechanisms and patient adherence solutions, with capture occurring at manufacturing, distribution, and end-user application stages. The ecosystem’s structure emphasizes collaboration between technical enablers and healthcare stakeholders to ensure regulatory compliance and therapeutic efficacy.

Raw material/component suppliers — Provide polymers, sensors, and adhesives for device fabrication

Device manufacturers — Design and assemble non-invasive delivery systems (e.g., transdermal patches, nebulizers)

Technology developers — Innovate proprietary drug-release mechanisms and monitoring algorithms

Regulatory authorities — Oversee compliance with safety, quality, and performance standards

Distributors — Facilitate supply chain logistics to healthcare providers and pharmacies

Healthcare providers — Prescribe and administer devices to patients in clinical or home settings

Post-market service providers — Offer device maintenance, patient training, and data analytics support

Control points reside with regulatory bodies governing approvals and manufacturers defining technical specifications. Dependency risks include material shortages, patent litigation, and interoperability challenges with healthcare IT systems. Switching costs are moderate for providers due to device-specific training requirements, while partnerships between developers and pharma firms are critical to align delivery systems with drug formulation needs.

Recent Industry Insights

The Non-Invasive Drug Delivery Device market has witnessed transformative advancements over the past 18 months, driven by innovation in transdermal and pulmonary delivery systems. Strategic partnerships have accelerated R&D, with companies like MedTech Innovations collaborating with biopharma giants to co-develop smart patches for chronic disease management. Mergers & acquisitions have intensified, notably Aerothera’s acquisition of a niche startup specializing in dry powder inhalers, consolidating market share in respiratory care. Product launches highlight the rise of IoT-enabled devices, such as Respironics’ AI-powered nebulizer with real-time dosage tracking. Regulatory bodies, including the FDA, have streamlined approvals for non-invasive technologies, reflecting a shift toward patient-centric care models. Meanwhile, consumer demand for at-home treatment options has surged, pushing enterprises to prioritize user-friendly designs and discreet delivery methods. Funding rounds have also spiked, with Series A rounds like NanoDelivery Systems’ $50M raise fueling expansion in needle-free injectors. These trends underscore the Non-Invasive Drug Delivery Device industry trends shaping a future focused on precision, accessibility, and digital integration.

Analyst Overview

The Non-Invasive Drug Delivery Device market outlook remains robust, driven by rising demand for patient-centric therapies and advancements in chronic disease management. Market attractiveness is underscored by a projected CAGR of 7.5%–9.2%, fueled by aging demographics, biotech innovation, and regulatory support for alternative drug administration methods. However, competitive intensity is moderate to high, with established players dominating while startups leverage niche technologies like microneedles and smart inhalers. Strategic partnerships and mergers are critical for market differentiation.

Key Insights4 items

Long-term growth hinges on adoption in oncology and neurology sectors, where non-invasive solutions reduce hospitalization costs.

Innovation landscape is dynamic, with AI-driven dosing optimization and IoT-enabled devices reshaping patient adherence metrics.

Demand–supply balance tilts toward shortages in emerging markets due to fragmented manufacturing capabilities and stringent quality controls.

Key risk factors include regulatory delays, reimbursement complexities, and product liability litigation over novel delivery mechanisms.

Sustained investment in R&D and cross-sector collaborations will determine long-term success. Decision-makers must prioritize scalability, regulatory agility, and patient education to capitalize on this evolving landscape.

11 items

1. Executive Summary

2. Non-Invasive Drug Delivery Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Invasive Drug Delivery Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Non-Invasive Drug Delivery Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Diabetes Management

6.1.2. Vaccine Management

6.1.3. Pain Management

6.1.4. Respiratory Management

6.1.5. Others

6.2. Global Non-Invasive Drug Delivery Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Liquid-Based Needle-Free Injector

6.2.2. Powder-Based Needle-Free Injector

6.3. Global Non-Invasive Drug Delivery Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Non-Invasive Drug Delivery Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Invasive Drug Delivery Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Invasive Drug Delivery Device Market Competition by Key Manufacturers

8.1. Global Non-Invasive Drug Delivery Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Non-Invasive Drug Delivery Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Novartis AG

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Inovio Pharmaceuticals, Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Medtronic Plc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Tandem Diabetes Care, Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Teva Pharmaceutical Industries Ltd.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Crossject Medical Technology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Adherium Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sensirion AG

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Diabeloop

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. PharmaJet

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. PenJet

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Portal Instruments

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Capsule Technologies

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Propeller Health

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Invasive Drug Delivery Device Market

Figure 4: Global Non-Invasive Drug Delivery Device Market: Drivers

Figure 5: Global Non-Invasive Drug Delivery Device Market: Challenges

Figure 6: Global Non-Invasive Drug Delivery Device Market: Trends

Figure 7: Global Non-Invasive Drug Delivery Device Market: Opportunity

Figure 8: Global Non-Invasive Drug Delivery Device Market: Restraint

Figure 9: Global Non-Invasive Drug Delivery Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Non-Invasive Drug Delivery Device Market Value (USD Million) By Region

Figure 15: Global Non-Invasive Drug Delivery Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Non-Invasive Drug Delivery Device Market Value (USD Million) By Region

Figure 23: Global Non-Invasive Drug Delivery Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Invasive Drug Delivery Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Invasive Drug Delivery Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Invasive Drug Delivery Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Non-Invasive Drug Delivery Device Market Value (USD Million) By Region

Table 10: Global Non-Invasive Drug Delivery Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Non-Invasive Drug Delivery Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Non-Invasive Drug Delivery Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Non-Invasive Drug Delivery Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Novartis AG Basic Information And Sales Area

Table 31: Novartis AG. Products Portfolio

Table 32: Inovio Pharmaceuticals, Inc. Basic Information And Sales Area

Table 33: Inovio Pharmaceuticals, Inc.. Products Portfolio

Table 34: Medtronic Plc. Basic Information And Sales Area

Table 35: Medtronic Plc.. Products Portfolio

Table 36: Tandem Diabetes Care, Inc. Basic Information And Sales Area

Table 37: Tandem Diabetes Care, Inc.. Products Portfolio

Table 38: Teva Pharmaceutical Industries Ltd. Basic Information And Sales Area

Table 39: Teva Pharmaceutical Industries Ltd.. Products Portfolio

Table 40: Crossject Medical Technology Basic Information And Sales Area

Table 41: Crossject Medical Technology. Products Portfolio

Table 42: Adherium Ltd. Basic Information And Sales Area

Table 43: Adherium Ltd.. Products Portfolio

Table 44: Sensirion AG Basic Information And Sales Area

Table 45: Sensirion AG. Products Portfolio

Table 46: Diabeloop Basic Information And Sales Area

Table 47: Diabeloop. Products Portfolio

Table 48: PharmaJet Basic Information And Sales Area

Table 49: PharmaJet. Products Portfolio

Table 50: PenJet Basic Information And Sales Area

Table 51: PenJet. Products Portfolio

Table 52: Portal Instruments Basic Information And Sales Area

Table 53: Portal Instruments. Products Portfolio

Table 54: Capsule Technologies Basic Information And Sales Area

Table 55: Capsule Technologies. Products Portfolio

Table 56: Propeller Health Basic Information And Sales Area

Table 57: Propeller Health. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Non-Invasive Drug Delivery Device Market Value (USD Million) By Region

Table 63: Global Non-Invasive Drug Delivery Device Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Non-Invasive Drug Delivery Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	23.48 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Novartis AG; Inovio Pharmaceuticals, Inc.; Medtronic Plc.; Tandem Diabetes Care, Inc.; Teva Pharmaceutical Industries Ltd.; Crossject Medical Technology; Adherium Ltd.; Sensirion AG; Diabeloop; PharmaJet; PenJet; Portal Instruments; Capsule Technologies; Propeller Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options